Nalaganje...

Efficacy and safety of laquinimod in multiple sclerosis: current status

Laquinimod is a novel immunomodulatory agent, in development as a potential disease-modifying treatment for multiple sclerosis (MS). Structurally related to linomide, its pharmacological predecessor, laquinimod combines anti-inflammatory and possibly clinically relevant neuroprotective effects with...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Haggiag, Shalom, Ruggieri, Serena, Gasperini, Claudio
Format: Artigo
Jezik:Inglês
Izdano: SAGE Publications 2013
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3825117/
https://ncbi.nlm.nih.gov/pubmed/24228070
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756285613499424
Oznake: Označite
Brez oznak, prvi označite!